SUPPLEMENTARY INFORMATION doi:[removed]nature11156 Supplementary Figure 1 a

First Page		Document Content
Date: 2012-10-24 12:41:23 Bristol-Myers Squibb Cetuximab KRAS Oncogenes Ras subfamily Colorectal cancer Immunohistochemistry Medicine Anatomy Biology		SUPPLEMENTARY INFORMATION doi:[removed]nature11156 Supplementary Figure 1 a Add to Reading List Source URL: openwetware.org Download Document from Source Website File Size: 3,52 MB Share Document on Facebook

	Stuttgart Research Center Systems Biology (SRCSB) Systems Biology Seminar Talk „Heterogeneity and druginduced plasticity in colorectal cancer“ DocID: 1voOg - View Document
	Histopathology 2007, 50, 113–130. DOI: j02549.x REVIEW Classification of colorectal cancer based on correlation of clinical, morphological and molecular features DocID: 1vkot - View Document
	TUESDAY POSTER PRESENTATION TP01 - Cancer, Clinical and Translational Proteomics MO01-001 Verification of colorectal cancer biomarker candidates in plasma/serum extracellular vesicles by targeted proteomics Takeshi Tomon DocID: 1v6qe - View Document
	License Agreement to Develop Colorectal Cancer Risk Assessment Test DocID: 1v4r9 - View Document
	UNIVERSITY HOSPITAL & CLINICS COLORECTAL CANCER IN ACADIANA 2017 PHYSICIAN STUDY Overview: Colorectal cancer is the third leading type of cancer diagnosed in the U.S. There was an estimated 135,430 cases inColorec DocID: 1uS1a - View Document